Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...
Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Nov. 12, 2025 — AISAP, a provider of AI Point-of-Care Diagnostics, has announced a field initiative in Ghana, deploying ...
Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...
Nov. 10, 2025 — Kestra Medical Technologies, a wearable medical device and digital healthcare company, has announced ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Nov. 10, 2025 — Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its latest generation ...
Nov. 8, 2025 — Sanjay Rajagopalan, MD, MBA, Chief of Cardiovascular Medicine at University Hospitals Harrington Heart & ...
Nov. 10, 2025 — Sentante, a med-tech robotics company, has successfully demonstrated a first-of-a-kind remote stroke ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Nov. 4, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on treating calcified arterial disease ...
Nov. 3, 2025 — Penumbra, Inc. has announced additional results of the STORM-PE randomized controlled trial (RCT), which ...
Nov. 4, 2025 – Johnson & Johnson MedTech has announced the one-year results in patients treated with its Shockwave ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Nov. 3, 2025 — GE HealthCare and AliveCor recently announced the world’s first clinical go-live of the integration ...
Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...
Oct. 30, 2025 — Recor Medical and its parent company, Otsuka Medical Devices presented the results from two clinical ...
November 13, 2025
